These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 22413022

  • 1. Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
    Fraga AG, Martins TG, Torrado E, Huygen K, Portaels F, Silva MT, Castro AG, Pedrosa J.
    PLoS One; 2012; 7(3):e33406. PubMed ID: 22413022
    [Abstract] [Full Text] [Related]

  • 2. BCG-mediated protection against Mycobacterium ulcerans infection in the mouse.
    Converse PJ, Almeida DV, Nuermberger EL, Grosset JH.
    PLoS Negl Trop Dis; 2011 Mar 15; 5(3):e985. PubMed ID: 21423646
    [Abstract] [Full Text] [Related]

  • 3. Analysis of the vaccine potential of plasmid DNA encoding nine mycolactone polyketide synthase domains in Mycobacterium ulcerans infected mice.
    Roupie V, Pidot SJ, Einarsdottir T, Van Den Poel C, Jurion F, Stinear TP, Huygen K.
    PLoS Negl Trop Dis; 2014 Mar 15; 8(1):e2604. PubMed ID: 24392169
    [Abstract] [Full Text] [Related]

  • 4. Vaccine-Specific Immune Responses against Mycobacterium ulcerans Infection in a Low-Dose Murine Challenge Model.
    Mangas KM, Buultjens AH, Porter JL, Baines SL, Marion E, Marsollier L, Tobias NJ, Pidot SJ, Quinn KM, Price DJ, Kedzierska K, Zeng W, Jackson DC, Chua BY, Stinear TP.
    Infect Immun; 2020 Feb 20; 88(3):. PubMed ID: 31818964
    [Abstract] [Full Text] [Related]

  • 5. Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer.
    Bolz M, Bénard A, Dreyer AM, Kerber S, Vettiger A, Oehlmann W, Singh M, Duthie MS, Pluschke G.
    PLoS Negl Trop Dis; 2016 Feb 20; 10(2):e0004431. PubMed ID: 26849213
    [Abstract] [Full Text] [Related]

  • 6. Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.
    Hart BE, Hale LP, Lee S.
    PLoS Negl Trop Dis; 2015 Sep 20; 9(9):e0004046. PubMed ID: 26393347
    [Abstract] [Full Text] [Related]

  • 7. Protective effect of a dewaxed whole-cell vaccine against Mycobacterium ulcerans infection in mice.
    Watanabe M, Nakamura H, Nabekura R, Shinoda N, Suzuki E, Saito H.
    Vaccine; 2015 May 05; 33(19):2232-2239. PubMed ID: 25825332
    [Abstract] [Full Text] [Related]

  • 8. Mycobacterium ulcerans triggers T-cell immunity followed by local and regional but not systemic immunosuppression.
    Fraga AG, Cruz A, Martins TG, Torrado E, Saraiva M, Pereira DR, Meyers WM, Portaels F, Silva MT, Castro AG, Pedrosa J.
    Infect Immun; 2011 Jan 05; 79(1):421-30. PubMed ID: 20974825
    [Abstract] [Full Text] [Related]

  • 9. Local and regional re-establishment of cellular immunity during curative antibiotherapy of murine Mycobacterium ulcerans infection.
    Martins TG, Gama JB, Fraga AG, Saraiva M, Silva MT, Castro AG, Pedrosa J.
    PLoS One; 2012 Jan 05; 7(2):e32740. PubMed ID: 22393444
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine Efficacy.
    Hart BE, Lee S.
    PLoS Negl Trop Dis; 2016 Dec 05; 10(12):e0005229. PubMed ID: 27941982
    [Abstract] [Full Text] [Related]

  • 11. A Mycobacterium ulcerans vaccine pilot trial using an accurate low-dose challenge.
    Muhi S, Porter JL, Stinear TP.
    Microbiol Spectr; 2024 Aug 06; 12(8):e0055524. PubMed ID: 38916323
    [Abstract] [Full Text] [Related]

  • 12. Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.
    Hong H, Coutanceau E, Leclerc M, Caleechurn L, Leadlay PF, Demangel C.
    PLoS Negl Trop Dis; 2008 Aug 06; 2(10):e325. PubMed ID: 18941518
    [Abstract] [Full Text] [Related]

  • 13. The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer.
    Hall BS, Hsieh LT, Sacre S, Simmonds RE.
    Front Immunol; 2021 Aug 06; 12():788146. PubMed ID: 35154073
    [Abstract] [Full Text] [Related]

  • 14. Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model.
    Bolz M, Ruggli N, Borel N, Pluschke G, Ruf MT.
    PLoS Negl Trop Dis; 2016 Apr 06; 10(4):e0004678. PubMed ID: 27128097
    [Abstract] [Full Text] [Related]

  • 15. Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice.
    Bieri R, Bolz M, Ruf MT, Pluschke G.
    PLoS Negl Trop Dis; 2016 Feb 06; 10(2):e0004450. PubMed ID: 26863011
    [Abstract] [Full Text] [Related]

  • 16. IFN-gamma-dependent activation of macrophages during experimental infections by Mycobacterium ulcerans is impaired by the toxin mycolactone.
    Torrado E, Fraga AG, Logarinho E, Martins TG, Carmona JA, Gama JB, Carvalho MA, Proença F, Castro AG, Pedrosa J.
    J Immunol; 2010 Jan 15; 184(2):947-55. PubMed ID: 20008288
    [Abstract] [Full Text] [Related]

  • 17. Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad model.
    Trigo G, Martins TG, Fraga AG, Longatto-Filho A, Castro AG, Azeredo J, Pedrosa J.
    PLoS Negl Trop Dis; 2013 Jan 15; 7(4):e2183. PubMed ID: 23638204
    [Abstract] [Full Text] [Related]

  • 18. Mycolactone-mediated inhibition of tumor necrosis factor production by macrophages infected with Mycobacterium ulcerans has implications for the control of infection.
    Torrado E, Adusumilli S, Fraga AG, Small PL, Castro AG, Pedrosa J.
    Infect Immun; 2007 Aug 15; 75(8):3979-88. PubMed ID: 17517872
    [Abstract] [Full Text] [Related]

  • 19. [Role of mycolactone in the nerve damage of Buruli ulcer (Mycobacterium ulcerans infection)].
    En J, Ishii N, Goto M.
    Nihon Hansenbyo Gakkai Zasshi; 2011 Feb 15; 80(1):5-10. PubMed ID: 21404590
    [Abstract] [Full Text] [Related]

  • 20. Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer.
    Tanghe A, Content J, Van Vooren JP, Portaels F, Huygen K.
    Infect Immun; 2001 Sep 15; 69(9):5403-11. PubMed ID: 11500410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.